Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer.
J. L. Yu
No relevant relationships to disclose
C. E. Simmons
No relevant relationships to disclose
C. Victor
No relevant relationships to disclose
D. Han
No relevant relationships to disclose
S. Hogeveen
No relevant relationships to disclose
N. B. Leighl
No relevant relationships to disclose
S. Verma
No relevant relationships to disclose